Anwar R Padhani
Overview
Explore the profile of Anwar R Padhani including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
208
Citations
8686
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Padhani A, Papanikolaou N
Eur Radiol
. 2025 Mar;
PMID: 40055229
This special report explores the integration of artificial intelligence (AI) into prostate MRI workflows to address limitations associated with single-reader interpretations, such as inter-reader variability and diagnostic errors. We review...
2.
Giganti F, Moreira da Silva N, Yeung M, Davies L, Frary A, Ferrer Rodriguez M, et al.
Eur Radiol
. 2025 Feb;
PMID: 40016318
Objectives: Multi-centre, multi-vendor validation of artificial intelligence (AI) software to detect clinically significant prostate cancer (PCa) using multiparametric magnetic resonance imaging (MRI) is lacking. We compared a new AI solution,...
3.
MRI in Prostate Cancer Screening: A Review and Recommendations, From the Special Series on Screening
Schoots I, Haider M, Punwani S, Padhani A
AJR Am J Roentgenol
. 2025 Feb;
PMID: 39969143
Traditional PSA-based screening for prostate cancer (PCa) is challenged by an unfavorable benefit-to-harm ratio from underdiagnosis of clinically significant cancers, overdiagnosis of indolent cancers, and unnecessary biopsies, despite demonstrated reductions...
4.
Panebianco V, Catalano C, Sanguedolce F, De Santis M, Padhani A
Eur Radiol
. 2025 Jan;
PMID: 39890618
No abstract available.
5.
6.
Woo S, Vargas H, Padhani A
Korean J Radiol
. 2024 Nov;
25(12):1033-1035.
PMID: 39543864
No abstract available.
7.
Van Damme J, Tombal B, Michoux N, Van Nieuwenhove S, Pasoglou V, Triqueneaux P, et al.
Eur Urol Oncol
. 2024 Nov;
PMID: 39505670
Background And Objectives: We assessed the agreement between prostate-specific antigen (PSA) and imaging responses using whole-body magnetic resonance imaging (wbMRI). Our aim was to explore the potential prognostic value of...
8.
Sanguedolce F, Lauwers C, Tedde A, Basile G, Chernysheva D, Uleri A, et al.
Eur Urol Oncol
. 2024 Oct;
PMID: 39455339
Background And Objective: Intensification of targeted biopsy (TBx) around a magnetic resonance imaging (MRI)-visible lesion with regional biopsy (RBx) could obviate the need for systematic biopsy (SBx). We aimed to...
9.
Twilt J, Saha A, Bosma J, van Ginneken B, Bjartell A, Padhani A, et al.
Eur Urol
. 2024 Oct;
87(2):240-250.
PMID: 39438187
Background And Objective: Biparametric magnetic resonance imaging (bpMRI), excluding dynamic contrast-enhanced (DCE) magnetic resonance imaging (MRI), is a potential replacement for multiparametric MRI (mpMRI) in diagnosing clinically significant prostate cancer...
10.
Pollock J, Woo S, Padhani A, Gorin M, Tempany C, Tan N
AJR Am J Roentgenol
. 2024 Oct;
223(6):e2432099.
PMID: 39413233
No abstract available.